These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11222313)

  • 1. Meanfield approach to the thermodynamics of protein-solvent systems with application to p53.
    Völkel AR; Noolandi J
    Biophys J; 2001 Mar; 80(3):1524-37. PubMed ID: 11222313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A meanfield approach to the thermodynamics of a protein-solvent system with application to the oligomerization of the tumor suppressor p53.
    Noolandi J; Davison TS; Volkel AR; Nie X; Kay C; Arrowsmith CH
    Proc Natl Acad Sci U S A; 2000 Aug; 97(18):9955-60. PubMed ID: 10944184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Streptavidin tetramerization and 2D crystallization: a mean-field approach.
    Coussaert T; Völkel AR; Noolandi J; Gast AP
    Biophys J; 2001 Apr; 80(4):2004-10. PubMed ID: 11259313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutually compensatory mutations during evolution of the tetramerization domain of tumor suppressor p53 lead to impaired hetero-oligomerization.
    Mateu MG; Fersht AR
    Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3595-9. PubMed ID: 10097082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solvent-exposed residues located in the beta-sheet modulate the stability of the tetramerization domain of p53--a structural and combinatorial approach.
    Mora P; Carbajo RJ; Pineda-Lucena A; Sánchez del Pino MM; Pérez-Payá E
    Proteins; 2008 Jun; 71(4):1670-85. PubMed ID: 18076077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In the quest for stable rescuing mutants of p53: computational mutagenesis of flexible loop L1.
    Pan Y; Ma B; Venkataraghavan RB; Levine AJ; Nussinov R
    Biochemistry; 2005 Feb; 44(5):1423-32. PubMed ID: 15683227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of void volumes in proteins and application to stability of the p53 tumour suppressor protein.
    Cuff AL; Martin AC
    J Mol Biol; 2004 Dec; 344(5):1199-209. PubMed ID: 15561139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alanine scanning mutagenesis of the alpha-helix 115-123 of phage T4 lysozyme: effects on structure, stability and the binding of solvent.
    Blaber M; Baase WA; Gassner N; Matthews BW
    J Mol Biol; 1995 Feb; 246(2):317-30. PubMed ID: 7869383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disentangling the perturbational effects of amino acid substitutions in the DNA-binding domain of p53.
    Wacey AI; Cooper DN; Liney D; Hovig E; Krawczak M
    Hum Genet; 1999 Jan; 104(1):15-22. PubMed ID: 10071187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking.
    Stommel JM; Marchenko ND; Jimenez GS; Moll UM; Hope TJ; Wahl GM
    EMBO J; 1999 Mar; 18(6):1660-72. PubMed ID: 10075936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel approach to protein-protein interaction: complex formation between the p53 tumor suppressor and the HIV Tat proteins.
    Longo F; Marchetti MA; Castagnoli L; Battaglia PA; Gigliani F
    Biochem Biophys Res Commun; 1995 Jan; 206(1):326-34. PubMed ID: 7818536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folding of tetrameric p53: oligomerization and tumorigenic mutations induce misfolding and loss of function.
    Lubin DJ; Butler JS; Loh SN
    J Mol Biol; 2010 Jan; 395(4):705-16. PubMed ID: 19913028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Change in oligomerization specificity of the p53 tetramerization domain by hydrophobic amino acid substitutions.
    Stavridi ES; Chehab NH; Caruso LC; Halazonetis TD
    Protein Sci; 1999 Sep; 8(9):1773-9. PubMed ID: 10493578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-resolution structure of the p53 core domain: implications for binding small-molecule stabilizing compounds.
    Ho WC; Luo C; Zhao K; Chai X; Fitzgerald MX; Marmorstein R
    Acta Crystallogr D Biol Crystallogr; 2006 Dec; 62(Pt 12):1484-93. PubMed ID: 17139084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of oligomeric stability by covalent linkage and its application to the human p53tet domain: thermodynamics and biological implications.
    Poon GM
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1574-8. PubMed ID: 18031269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability effects of increasing the hydrophobicity of solvent-exposed side chains in staphylococcal nuclease.
    Schwehm JM; Kristyanne ES; Biggers CC; Stites WE
    Biochemistry; 1998 May; 37(19):6939-48. PubMed ID: 9578580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a function-specific mutation of clathrin heavy chain (CHC) required for p53 transactivation.
    Ohata H; Ota N; Shirouzu M; Yokoyama S; Yokota J; Taya Y; Enari M
    J Mol Biol; 2009 Dec; 394(3):460-71. PubMed ID: 19766654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and functionality of a designed p53 dimer.
    Davison TS; Nie X; Ma W; Lin Y; Kay C; Benchimol S; Arrowsmith CH
    J Mol Biol; 2001 Mar; 307(2):605-17. PubMed ID: 11254385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stabilization of human triosephosphate isomerase by improvement of the stability of individual alpha-helices in dimeric as well as monomeric forms of the protein.
    Mainfroid V; Mande SC; Hol WG; Martial JA; Goraj K
    Biochemistry; 1996 Apr; 35(13):4110-7. PubMed ID: 8672446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nine hydrophobic side chains are key determinants of the thermodynamic stability and oligomerization status of tumour suppressor p53 tetramerization domain.
    Mateu MG; Fersht AR
    EMBO J; 1998 May; 17(10):2748-58. PubMed ID: 9582268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.